By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Asterias Biotherapeutics 

230 Constitution Drive

Menlo Park  California  94025  U.S.A.
Phone: 650-433-2992 Fax: n/a



Company News
Asterias Biotherapeutics Receives Orphan Drug Designation For AST-OPC1 For The Treatment Of Acute Spinal Cord Injury 2/4/2016 6:07:58 AM
Asterias Biotherapeutics To Present At The 18th Annual BIO CEO & Investor Conference 2/2/2016 9:01:29 AM
Asterias Biotherapeutics Announces Completion Of Transfer Of AST-VAC2 Manufacturing Process To Cancer Research UK As Milestone Towards Initiating Phase 1/2 Clinical Trial 1/21/2016 6:06:37 AM
Asterias Biotherapeutics To Present At Biotech Showcase 2016 1/6/2016 10:53:23 AM
Asterias Biotherapeutics Reports Third Quarter Results 11/10/2015 7:52:48 AM
Asterias Biotherapeutics To Report Third Quarter Results On November 9, 2015 11/6/2015 7:26:21 AM
Georgia Erbez Appointed Chief Financial Officer Of Asterias Biotherapeutics 11/2/2015 6:11:47 AM
Asterias Biotherapeutics To Begin Dose Escalation In The SCiStar Phase 1/2a Clinical Trial Of AST-OPC1 For Complete Cervical Spinal Cord Injury 10/20/2015 7:49:11 AM
Asterias Biotherapeutics To Participate In Webcast On Innovations In Regenerative Medicine & Curative Biologics 10/13/2015 8:17:53 AM
Asterias Biotherapeutics Announces Collaboration With Cell Therapy Catapult To Scale Production Of AST-VAC2 10/13/2015 6:06:17 AM